L A Cysique

Summary

Affiliation: University of New South Wales
Country: Australia

Publications

  1. ncbi Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression
    Lucette A Cysique
    Brain Sciences, University of New South Wales, Sydney, Australia
    J Neurovirol 17:176-83. 2011
  2. ncbi HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon
    Georgette D Kanmogne
    Department of Pharmacology and Experimental Neurosciences, University of Nebraska Medical Center, Omaha, NE, USA
    BMC Neurol 10:60. 2010
  3. ncbi Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review
    Lucette A Cysique
    Brain Sciences, University of New South Wales, and Department of Neurology, Xavier Building, Level 4, St Vincent s Hospital, 390 Victoria Street, Sydney, NSW, 2010, Australia
    Neuropsychol Rev 19:169-85. 2009
  4. ncbi Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy
    L A Cysique
    Department of Psychiatry, University of California at San Diego, CA, USA
    Neurology 73:342-8. 2009
  5. ncbi Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research
    Lucette A Cysique
    Departments of Neurology and HIV Medicine, St, Vincent s Hospital, Sydney, Australia
    BMC Neurol 11:148. 2011
  6. ncbi A screening algorithm for HIV-associated neurocognitive disorders
    L A Cysique
    Brain Sciences, University of New South Wales, Sydney, Australia
    HIV Med 11:642-9. 2010

Collaborators

Detail Information

Publications6

  1. ncbi Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression
    Lucette A Cysique
    Brain Sciences, University of New South Wales, Sydney, Australia
    J Neurovirol 17:176-83. 2011
    ..Nonetheless, predictive modelling with these last two factors misclassified 27% and had low sensitivity (43%) emphasising that other yet-to-be-defined factors were operative...
  2. ncbi HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon
    Georgette D Kanmogne
    Department of Pharmacology and Experimental Neurosciences, University of Nebraska Medical Center, Omaha, NE, USA
    BMC Neurol 10:60. 2010
    ..The objectives of this study were to determine whether Western neuropsychological (NP) methods are appropriate for use in Cameroon, and to evaluate cognitive function in a sample of HIV-infected adults...
  3. ncbi Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review
    Lucette A Cysique
    Brain Sciences, University of New South Wales, and Department of Neurology, Xavier Building, Level 4, St Vincent s Hospital, 390 Victoria Street, Sydney, NSW, 2010, Australia
    Neuropsychol Rev 19:169-85. 2009
    ..The review emphasizes the need to address methodological limitations of published studies and the need for large and representative cross-disciplinary longitudinal investigations across the HIV illness span...
  4. ncbi Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy
    L A Cysique
    Department of Psychiatry, University of California at San Diego, CA, USA
    Neurology 73:342-8. 2009
    ....
  5. ncbi Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research
    Lucette A Cysique
    Departments of Neurology and HIV Medicine, St, Vincent s Hospital, Sydney, Australia
    BMC Neurol 11:148. 2011
    ..The current review aims to better synthesise existing literature by using an innovative two-phase review approach (qualitative and quantitative) to overcome methodological differences between studies...
  6. ncbi A screening algorithm for HIV-associated neurocognitive disorders
    L A Cysique
    Brain Sciences, University of New South Wales, Sydney, Australia
    HIV Med 11:642-9. 2010
    ....